Form D · Biotechnology
Aptorum Group Ltd
Hong Kong, K3 · CIK 0001734005
Offering snapshot reported May 25, 2018 · SEC filing
- Reported sold
- $1.6M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 14, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2018 | Initial | $1,600,400 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $68.5K
- Finders' fees
- $0
- Form D file number
- 021-313300
$150,000 of the Offering was sold pursuant to Regulation D; $1,450,400 was sold pursuant to Regulation S.
Convertible Note into Ordinary Shares
Warrants to purchase a number of Class A Ordinary Shares equal to 5.5% of the number of Class A Ordinary Shares issuable upon conversion of the Series A Notes issued in the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Boustead Securities, LLC | 141391 | |
| China Renaissance Securities (Hong Kong) Limited | 166318 | China Renaissance Securities (Hong Kong) Limited · CRD 166318 |
Source: Form D, filed May 25, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Arner | Director |
| Charles Bathurst | Director |
| Keith Chan | Executive |
| Clark Cheng | Director |
| Ian Huen | Director, Executive |
| Sabrina Khan | Executive |
| Darren Lui | Director, Executive |
| Mirko Scherer | Director |
| Justin Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
17 Th Floor, Guangdong Investment Tower 148 Connaught Road Central
Hong Kong, K3, 000000
Hong Kong, K3, 000000